|
CASP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74138481412456E-12 |
| Normal-vs-Stage2 |
1.563690E-03 |
| Normal-vs-Stage3 |
4.214800E-04 |
| Normal-vs-Stage4 |
4.62030000003555E-06 |
| Stage1-vs-Stage2 |
7.774200E-01 |
| Stage1-vs-Stage3 |
3.820400E-01 |
| Stage1-vs-Stage4 |
1.226370E-01 |
| Stage2-vs-Stage3 |
6.647800E-01 |
| Stage2-vs-Stage4 |
4.875800E-01 |
| Stage3-vs-Stage4 |
7.799400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.54039999539424E-08 |
| Normal-vs-Asian |
1.452790E-01 |
| Caucasian-vs-AfricanAmerican |
5.780400E-01 |
| Caucasian-vs-Asian |
5.033400E-01 |
| AfricanAmerican-vs-Asian |
6.204800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
5.84750026177971E-10 |
| Male-vs-Female |
8.519600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.63880000000028E-05 |
| Normal-vs-Extreme_Weight |
1.13809994761738E-09 |
| Normal-vs-Obese |
4.50159909348713E-11 |
| Normal-vs-Extreme_Obese |
8.638300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.377800E-02 |
| Normal_Weight-vs-Obese |
7.013800E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.792600E-01 |
| Extreme_Weight-vs-Obese |
9.587200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.304400E-01 |
| Obese-vs-Extreme_Obese |
2.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.354300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.66010538649175E-11 |
| Normal-vs-Age(81-100Yrs) |
1.158950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.843800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.144810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.464000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.569760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.989780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.582600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.010400E-02 |
| Normal-VS-KIRP CIMP |
1.244850E-03 |
| Normal-VS-Unclassified PRCC |
1.76208000000067E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.33066907387547E-16 |
| Type1 PRCC-VS-KIRP CIMP |
2.796200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.710300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.957200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.164870E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.888600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.15310000000391E-05 |
| Normal-vs-N1 |
5.97339999999225E-05 |
| Normal-vs-N2 |
1.837940E-04 |
| N0-vs-N1 |
2.168800E-01 |
| N0-vs-N2 |
6.618400E-01 |
| N1-vs-N2 |
8.664800E-01 |
|
|
